ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 3 Study Areas Where Your IRT Vendor Should Do More

  Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.

• Why Oncology Drug Development Lags In Digital Biomarkers

  Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.

• How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

  Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

• Using eConsent Data To Populate Site And Sponsor Data Systems

  A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

• The Regulatory Binder Checklist For Clinical Trial Sites

  By following this checklist, research teams can enhance organizational efficiency, maintain compliance with regulatory standards, and confidently navigate the complexities of documentation management.

• How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?

  Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?

• 10 Questions To Ask When Looking For An eClinical Platform

  Stakeholders should ask these questions when aiming to enhance the integrity and efficiency of their clinical trials while minimizing risks associated with inadequate eClinical solutions.

• Addressing The Specific Complexities Of Oncology eCOA Clinical Trials

  What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

• Flexible By Design: Support For Early-Phase Oncology Trial

  Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.

• Avoid Database Go-Live Delays With The Right EDC System

  If you are looking to speed up your start-up process, selecting a reliable EDC System is key.